Respiratory failure following isolated ziprasidone ingestion in a toddler

Journal of Medical Toxicology

Volumn 6, Issue 1, 2010, Pages 41-43

  Gresham, Chip ^a,d   Ruha, Anne M ^a,b,c  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^b MARICOPA MEDICAL CENTER   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^d NONE   (New Zealand)

Author keywords

Ingestion; Respiratory failure; Toxicology; Ziprasidone

Indexed keywords

ACTIVATED CARBON; MIDAZOLAM; NEUROMUSCULAR BLOCKING AGENT; SODIUM CHLORIDE; ZIPRASIDONE;

ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM DEPRESSION; CHILD; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; EMERGENCY WARD; ENDOTRACHEAL INTUBATION; EXTUBATION; HOSPITAL DISCHARGE; HUMAN; INGESTION; LETHARGY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RESPIRATORY FAILURE; TABLET; TOXICOKINETICS;

ACCIDENTS; ANTIPSYCHOTIC AGENTS; CHROMATOGRAPHY, LIQUID; HUMANS; HYPNOTICS AND SEDATIVES; INFANT; INTUBATION, INTRATRACHEAL; MALE; MASS SPECTROMETRY; MIDAZOLAM; PIPERAZINES; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; THIAZOLES; TREATMENT OUTCOME;

EID: 77951937283     PISSN: 15569039     EISSN: 19376995     Source Type: Journal    
DOI: 10.1007/s13181-010-0035-4     Document Type: Article

References (16)

1. Malone RP, Delaney MA, Hyman SB et al (2007) Ziprasidone in adolescents with autism: an open-label pilot study. J Child Adolesc Psychopharmacol 17(6):779-790
2. Biederman J, Mick E, Spencer T et al (2007) A prospective open-label treatment trial of ziprasidone monotherapy in children and adolescents with bipolar disorder. Bipolar Disord 9(8):888-894
3. LoVecchio F, Watts D, Eckholdt P (2004) Three-year experience with ziprasidone exposures [letter]. Am J Emerg Med 23(4):586-587
4. Reilly TH, Kirk MA (2007) Atypical antipsychotics and newer antidepressants. Emerg Med Clin North Am 25:477-497
5. Lackey G, Alsop J, Albertson T (2002) A one year review of pediatric ziprasidone ingestions [abstract]. J Toxicol Clin Toxicol 40(5):624
6. Bryant SM, Zilberstein J, Cumpston KL et al (2003) A case series of ziprasidone overdoses. Vet Hum Toxicol 45(2):81-82
7. Biswas AK, Zabrocki LA, Mayes KL et al (2003) Cardiotoxicity associated with intentional ziprasidone and buproprion overdose. J Toxicol Clin Toxicol 41(2):101-104
8. Anita SX, Sholevar EH, Baron DA (2005) Overdoses and ingestions of second-generation antipsychotics in children and adolescents. J Child Adolesc Psychopharmacol 15(6):970-985
9. Teich J (2003) Side effects of ziprasidone. Am J Psychiatry 160:1355-1356
10. Klein-Schwartz W, Lofton AL, Benson BE et al (2007) Prospective observational multi-poison center study of ziprasidone exposures. J Toxicol Clin Toxicol 45:782-786
11. Sallee FR, Miceli JJ, Tensfeldt T et al (2006) Single-dose pharmacokinetics and safety of ziprasidone in children and adolescents. J Am Acad Child Adolesc Psych 45(6):720-728
12. Isbister GK, Balit CR, Kilham HA (2005) Antipsychotic poisoning in young children. A systematic review. Drug Saf 28 (11):1029-1044
13. DuBoise D (2005) Toxicology and overdose of atypical antipsychotic medications in children: does newer necessarily mean safer? Curr Opin Pediatr 17(2):227-233
14. Lofton AL, Klein-Schwartz W, Spiller HA et al (2004) Prospective multi-center study of ziprasidone exposures [abstract]. J Toxicol Clin Toxicol 42(5):726
15. Forrester MB (2008) Pattern of ziprasidone exposures reported to Texas poison centers, 2001-2005. Human Exp Toxicol 27(4):355-361
16. Geodon [package insert] (2007). Pfizer, New York